Literature DB >> 30379369

Who diagnosed and prescribed what? Using provider details to inform observational research.

Greta A Bushnell1, Til Stürmer1, Christina Mack1,2, Virginia Pate1, Matthew Miller3.   

Abstract

PURPOSE: To describe how often patients with depression initiating antidepressants receive their depression diagnosis and prescriptions from the same provider and, when simultaneously initiating benzodiazepines, how often both prescriptions come from the same provider.
METHODS: Using a US healthcare claims database, we created a cohort of adults (18-64 years) with a depression diagnosis who initiated antidepressants. We examined concordance by provider specialty and provider identifier between (a) the first antidepressant prescription fill and most proximal depression diagnosis, and (b) the initial antidepressant and benzodiazepine prescription fills among simultaneous benzodiazepine and antidepressant initiators.
RESULTS: Among 245 166 antidepressant initiators with a recent depression diagnosis (female = 67%; median age = 39), the specialty of the provider assigning the depression diagnosis matched the antidepressant prescriber's specialty in 94% of cases with known provider details (provider identifier concordance = 93%). Concordance was higher for adults diagnosed by a general practitioner (98%) or psychiatrist (92%) than for those diagnosed by a psychologist (74%). In simultaneous new users of antidepressants and benzodiazepines (n = 19 371), both prescriptions were issued by the same provider specialty and provider identifier 94% and 93% of the time, respectively.
CONCLUSIONS: The vast majority of patients who received antidepressant prescriptions and depression diagnoses appear to have received both diagnosis and antidepressants from the same provider, suggesting that when antidepressants are issued around the time a patient is diagnosed with depression, the antidepressant was likely prescribed for depression. In addition, the great majority of patients who simultaneously initiate benzodiazepines appear to do so under the direction of one provider.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  claims database; concurrent prescribing; depression; observational research; pharmacoepidemiology; prescriber; provider concordance

Mesh:

Substances:

Year:  2018        PMID: 30379369      PMCID: PMC6407693          DOI: 10.1002/pds.4685

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  12 in total

1.  Guidelines for good database selection and use in pharmacoepidemiology research.

Authors:  Gillian C Hall; Brian Sauer; Alison Bourke; Jeffrey S Brown; Matthew W Reynolds; Robert LoCasale; Robert Lo Casale
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-11-08       Impact factor: 2.890

2.  Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.

Authors:  Sebastian Schneeweiss; Amanda R Patrick; Til Stürmer; M Alan Brookhart; Jerry Avorn; Malcolm Maclure; Kenneth J Rothman; Robert J Glynn
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

3.  Confounding by indication.

Authors:  A M Walker
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

4.  Proportion of antidepressants prescribed without a psychiatric diagnosis is growing.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

5.  Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015.

Authors:  Jenna Wong; Aude Motulsky; Tewodros Eguale; David L Buckeridge; Michal Abrahamowicz; Robyn Tamblyn
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

6.  Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.

Authors:  Greta A Bushnell; Til Stürmer; Bradley N Gaynes; Virginia Pate; Matthew Miller
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

7.  Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines.

Authors:  Mei-Sing Ong; Karen L Olson; Aurel Cami; Chunfu Liu; Fang Tian; Nandini Selvam; Kenneth D Mandl
Journal:  J Gen Intern Med       Date:  2015-07-18       Impact factor: 5.128

8.  Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.

Authors:  Jeremy A Rassen; M Alan Brookhart; Robert J Glynn; Murray A Mittleman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2009-04-05       Impact factor: 6.437

9.  Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.

Authors:  Greta A Bushnell; Til Stürmer; Sonja A Swanson; Alice White; Deborah Azrael; Virginia Pate; Matthew Miller
Journal:  Psychiatr Serv       Date:  2015-11-16       Impact factor: 3.084

10.  Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims.

Authors:  Anupam B Jena; Dana Goldman; Lesley Weaver; Pinar Karaca-Mandic
Journal:  BMJ       Date:  2014-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.